Jacquelien ten Dam
Director/Board Member bei MAUNA KEA TECHNOLOGIES
Profil
Jacquelien ten Dam is an Independent Director at Mauna Kea Technologies SA and the Chief Financial Officer at Mimetas BV.
She graduated from the University of Leiden.
Aktive Positionen von Jacquelien ten Dam
| Unternehmen | Position | Beginn |
|---|---|---|
| MAUNA KEA TECHNOLOGIES | Director/Board Member | 01.01.2021 |
Mimetas BV
 Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Director of Finance/CFO | - |
Ausbildung von Jacquelien ten Dam
| University of Leiden | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MAUNA KEA TECHNOLOGIES | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Mimetas BV
Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands. | Health Technology |
